Most definitely, these are merely near term targets only! Long term targets are still based on multi-billion dollar market capitals. What I look forward to witnessing is the mode of rise: whether that is a steady climb on our own accord, or rather if a big pharma bid elevates the price to triple digits overnight. All dependent upon study results of course.